MANCHESTER, England, April 1, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today provides a business update and reports financial results for the three and twelve months ended December 31, 2024.

Smartkem Chairman and CEO, Ian Jenks, commented: "During the fourth quarter of 2024, Smartkem made bold strides towards commercializing our advanced semiconductor materials, which enable flexible, transparent and lightweight MicroLED displays, an industry projected to grow to over $4 billion by 2030.¹We delivered on every key milestone during the quarter, and in December, we raised $7.65 million in equity financing and received a $1.1 million grant from Innovate UK - critical funding to supercharge our momentum, expand our resources, and support our ongoing programs.

"Our commercialization strategy is built on three pillars: advancing our polymer materials, developing EDA tools, and establishing scalable manufacturing processes. Concentrating on executing this strategy, we established some key goals for 2025, which included:

Commencing development work on a rollable, transparent MicroLED display with our partner, AUO;
Completing first sale of our TRUFLEX® materials to Chip Foundation under the terms of our co-development agreement;
Extending Technology Transfer Agreement with RiTdisplay to transfer Smartkem's OTFT process from ITRI to RiTdisplay's Gen2.5 line;
Entering into a joint development agreement for a "chip-first" MicroLED display;
Entering into additional collaboration and/or co-development agreements that further advance our technology toward commercialization; and
Producing a demonstration of a MicroLED display using our OTFT technology.

"Our early wins in 2025, including the project commencement with AUO and the first commercial sales of our TRUFLEX® advanced semiconductor materials show our focus on accelerating towards commercialization of our technology. We are well on our way to delivering further objectives set out including additional joint development agreements and product demonstrations at upcoming industry events. I look forward to updating you of our progress throughout the year as we continue to solidify our position as a global leader in organic transistor technology that has the potential to change the world of electronics," added Jenks.

Recent Business Highlights

Advanced strategic partnership with RiTdisplay Corporation, a leading developer of optoelectronic solutions, visual displays and passive-matrix OLED displays, in a new phase toward commercialization, including the planned integration of Smartkem's OTFT process on to RiTdisplay's Gen 2.5 Pilot Line.
Positioned to unveil the first MicroLED-in-a-Package (MiP) Backlight using Smartkem's unique and proprietary technology at this year's Touch Taiwan conference in Taipei City, Taiwan which runs from April 16-18^th 2025.
Completed first sale of TRUFLEX^® semiconductor materials to joint development partner, Chip Foundation, a manufacturer of semiconductor and integrated circuit devices, for use in the co-development of a new generation of MicroLED-based backlight technology for Liquid Crystal Displays.
Signed multi-year agreement with FlexiIC, a company providing innovation in the design of flexible integrated circuits and systems, to begin a new project to develop a new generation of CMOS for smart sensors.
Partnered with AUO, the largest display manufacturer in Taiwan, to jointly develop the world's first advanced rollable, transparent MicroLED display.
Appointed Jonathan Watkins as Chief Operating Officer (COO), with responsibility for global operations and strategic partnerships.
Participated at SEMICON® Korea 2025.

Full Year 2024 Financial Highlights:

Completed concurrent public and private offerings in December 2024 for aggregate proceeds of $7.65 million.
Received and accepted a £900,000 (USD 1.1 million) grant from Innovate UK for a project partnership with AUO to develop a rollable, transparent MicroLED display.
Cash and cash equivalents were $7.1 million as of December 31, 2024, compared to $8.8 million as of December 31, 2023.
Revenues were $82 thousand for the year ended December 31, 2024, up compared to $27 thousand for the same period of 2023, primarily due to an increase in the sale of demonstrator products to potential partners, as the company sought to expand its marketing efforts.
Operating expenses were $11.5 million for the year ended December 31, 2024, compared to $10.8 million for the same period of 2023.

About Smartkem

Smartkem is seeking to change the world of electronics with a new class of transistor using its proprietary advanced semiconductor materials. Its technology can be used in a range of applications including MicroLED, LCD and AMOLED displays, as well as advanced computer and AI chip packaging, and a new type of sensor.

In seeking to enable the adoption and mass commercialization of MicroLED displays, Smartkem's low temperature (80C) process allows its liquid transistors to be poured directly onto the MicroLEDs, eliminating many of the high-cost, low-yield manufacturing processes used in traditional production. This innovation reduces defects, enhances yield and integrates seamlessly into existing manufacturing infrastructure, making MicroLED displays more commercially viable across sectors including smartphones, wearables, automatives and digital signage.

Smartkem develops its materials at its research and development facility in Manchester, UK and provides prototyping services at the Centre for Process Innovation (CPI) at Sedgefield, UK. It has a field application office in Taiwan. The company has an extensive IP portfolio including 138 granted patents across 17 patent families, 16 pending patents and 40 codified trade secrets. For more information, visit our website or follow us on LinkedIn.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on Smartkem, Inc.'s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expect," "intend," "plan," "project," "believe," "estimate," and other similar or elated expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

Industry Representatives and Media
Selena Kirkwood
Head of Communications for Smartkem
T: +44 (0) 7971 460 364
s.kirkwood@smartkem.com

Analysts and Investors
David Barnard, CFA
Alliance Advisors Investor Relations
T: 1 415 433 3777
dbarnard@allianceadvisors.com

¹ 2024 Omdia Report

                                                                                    
            
              SMARTKEM, INC. AND SUBSIDIARIES


                                                                                           
            Consolidated Balance Sheets


                                                                            
            (in thousands, except number of shares and per share data)




                                                                                                                                                           December 31,               December 31,


                                                                                                                                                      2024                   2023



            
              Assets



            Current assets



            Cash and cash equivalents                                                                                                          $
         7,141             $
         8,836



            Accounts receivable                                                                                                                                                 268



            Research and development tax credit receivable                                                                                              519                      610



            Prepaid expenses and other current assets                                                                                                   849                      811



            Total current assets                                                                                                                      8,509                   10,525



            Property, plant and equipment, net                                                                                                          269                      455



            Right-of-use assets, net                                                                                                                    120                      285



            Other assets, non-current                                                                                                                     6                        7



            
              Total assets                                                                                                            $
         8,904            $
         11,272





            
              Liabilities and stockholders' equity



            Current liabilities



            Accounts payable and accrued expenses                                                                                              $
         1,791             $
         1,178



            Lease liabilities, current                                                                                                                   47                      230



            Other current liabilities                                                                                                                   450                      360



            Total current liabilities                                                                                                                 2,288                    1,768



            Lease liabilities, non-current                                                                                                               25                       19



            Warrant liability                                                                                                                                                 1,372



            Total liabilities                                                                                                                         2,313                    3,159





            Commitments and contingencies (Note 7)





            
              Stockholders' equity:



            Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized,
    856 and 13,765 shares issued and outstanding, at December 31, 2024
    and December 31, 2023, respectively



            Common stock, par value $0.0001 per share, 300,000,000 shares authorized,
    3,590,217 and 889,668 shares issued and outstanding, at December 31, 2024
    and December 31, 2023, respectively



            Additional paid-in capital                                                                                                              122,316                  104,757



            Accumulated other comprehensive loss                                                                                                    (1,105)                 (1,578)



            Accumulated deficit                                                                                                                   (114,620)                (95,066)



            Total stockholders' equity                                                                                                                6,591                    8,113



            
              Total liabilities and stockholders' equity                                                                              $
         8,904            $
         11,272

                                                                         
              
                SMARTKEM, INC. AND SUBSIDIARIES


                                                           
              
                Consolidated Statements of Operations and Comprehensive Loss


                                                                  
              (in thousands, except number of shares and per share data)




                                                                                                                                                                Year Ended December 31,


                                                                                                                                                           2024                          2023



     Revenue                                                                                                                                        $
            82                  $
              27



     Cost of revenue                                                                                                                                          32                              23



     Gross profit                                                                                                                                             50                               4





     Other operating income                                                                                                                                1,017                             836





     Operating expenses



     Research and development                                                                                                                              5,111                           5,556



     General and administrative                                                                                                                            6,342                           5,188



     (Gain)/loss on foreign currency transactions                                                                                                             78                              87



     Total operating expenses                                                                                                                             11,531                          10,831





     Loss from operations                                                                                                                               (10,464)                        (9,991)





     Non-operating income/(expense)



     Gain/(loss) on foreign currency transactions                                                                                                          (544)                          1,213



     Transaction costs allocable to warrants                                                                                                                                              (198)



     Change in fair value of the warrant liability                                                                                                           672                             465



     Interest income/(expense)                                                                                                                                 7                              12



     Total non-operating income/(expense)                                                                                                                    135                           1,492





     Loss before income taxes                                                                                                                           (10,329)                        (8,499)



     Income tax expense                                                                                                                                      (1)



     Net loss                                                                                                                                  $
           (10,330)            $
              (8,499)



     Preferred stock deemed dividends                                                                                                                    (9,224)



     Net loss attributed to common stockholders                                                                                                $
           (19,554)            $
              (8,499)





     Weighted average shares outstanding - basic and diluted                                                                                           3,260,127                       1,344,892





     Basic and diluted net loss per common share attributed to common stockholders                                                               $
           (6.00)             $
              (6.32)





     Net loss                                                                                                                                  $
           (10,330)            $
              (8,499)



     Other comprehensive loss:



     Foreign currency translation                                                                                                                            473                         (1,095)



     Total comprehensive loss                                                                                                                   $
           (9,857)            $
              (9,594)

Logo -

View original content:https://www.prnewswire.co.uk/news-releases/smartkem-reports-fourth-quarter-and-full-year-2024-financial-results-302416225.html

Images

Tags

More Like This

Smartkem Reports Third Quarter 2024 Financial Results

Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results

Smartkem Reports Second Quarter 2024 Financial Results

Smartkem Recaps 2024 Achievements and Sets 2025 Goals

Smartkem Closes $7.65 Million Offering

Smartkem Receives £900,000 Grant from Innovate UK for Advanced MicroLED Displays

Smartkem to Present and Exhibit at MicroLED Connect 2024

Smartkem to Participate at the ROTH 10th Annual London Conference